Dexmedetomidine as an adjuvant analgesic for intractable cancer pain.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21241196.
- Also identified by DOI 10.1089/jpm.2010.0235.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Abstract Dexmedetomidine (Precedex®) is an alpha-2 adrenergic agonist that can produce sedation and analgesia without causing respiratory depression. Its use has been described in patients undergoing mechanical ventilation, sedation for surgical and nonsurgical procedures, and prevention of withdrawal. We describe its use as an adjuvant analgesic in a patient with cancer pain refractory to multiple treatment modalities.
Medical subject headings
- Analgesics, Non-Narcotic
- Dexmedetomidine
- Neoplasms
- Intractable Pain